The Filing Desk

Claritev vs GoodRx

Claritev CTEV · GoodRx GDRX · Health Care Technology

Claritev reported revenue of $965 million in fiscal 2025, 1.2 times GoodRx's $797 million in fiscal 2025. Claritev's revenue grew 3.7% in its latest year, and GoodRx's grew 0.6%. Claritev had an operating margin of 3.0%, against 11.0% at GoodRx. Free cash flow was −$12 million at Claritev and $164 million at GoodRx.

Side by side

ClaritevGoodRx
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$965M$797M
Revenue growth3.7%0.6%
Revenue growth a year, last 5 years0.6%7.7%
Gross margin——
Operating margin3.0%11.0%
Net margin−29.4%3.8%
Free cash flow−$12M$164M
Free cash flow margin−1.3%20.6%
Return on capital0.5%5.8%
Net debt to EBITDA9.7x1.4x
Dividends and buybacks$0M$216M
Change in diluted share count1.8%−9.0%
Last close$19.03$3.02
P/E at the last close—75.5×
Insider trades, last 12 monthsbought $1.9 million, sold $919,352sold $9.7 million
Piotroski F-score5 of 86 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ClaritevGoodRx
Operating margin
Percent of revenue
ClaritevGoodRx
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ClaritevGoodRx

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Claritev and GoodRx pages.